Bill summaries are authored by CRS.

Shown Here:
Public Law (12/29/2006)

(This measure has not been amended since it was passed by the House on December 7, 2006. The summary of that version is repeated here.)

Office of National Drug Control Policy Reauthorization Act of 2006 - Title I: Organization of Office of National Drug Control Policy and Roles and Responsibilities - (Sec. 101) Amends the Office of National Drug Control Policy Reauthorization Act of 1998 (ONDCPRA) to include in the definition of demand reduction activities under such Act interventions for drug abuse and dependence, international drug control coordination and cooperation, and international drug abuse education, prevention, treatment, research, rehabilitation activities, and interventions for drug abuse and dependence.

Includes within the National Drug Control Program activities involving supply reduction, demand reduction, or state, local, and tribal affairs.

Redefines "state and local affairs" to include tribal affairs and coordination and enhancement of federal, state, local, and tribal law enforcement intelligence gathering initiatives relating to drug control among domestic law enforcement agencies.

Expands the definition of "supply reduction" activities to include: (1) law enforcement outside the United States; (2) source country programs; (3) activities to control international trafficking in, and availability of, illegal drugs; (4) activities to conduct and promote international law enforcement programs and policies to reduce the supply of drugs; and (5) sharing of domestic and foreign intelligence information.

Identifies as "appropriate congressional committees" for purposes of this Act: (1) the Senate Judiciary and Appropriations Committees and the Senate Caucus on International Narcotics Control; and (2) the House Government Reform, Judiciary, and Appropriations Committees.

(Sec. 102) Includes as a duty of the Office of National Drug Control Policy (Office) the development of specific goals and performance measurements for assessing the effectiveness of national drug control policy and programs. Grants cabinet status to the Director of the Office. Revises the duties and responsibilities of the Deputy Directors of the Office.

(Sec. 103) Designates the Deputy Director of National Drug Control Policy as the Acting Director in the Director's absence. Expands the duties of the Director to include: (1) coordination of private sector research and development of medications to treat addiction; (2) involvement of state, local, and tribal officials in the formulation and implementation of the National Drug Control Strategy; (3) monitoring of the allocation of resources among federal law enforcement agencies in response to drug trafficking and production threats; (4) reporting to Congress on drug reduction activities.

Requires National Drug Control Program budget requests and fund control notices to be submitted to the appropriate congressional committees.

Establishes the position of U.S. Interdiction Coordinator for the coordination of drug interdiction operations among National Drug Control Program agencies and the development and issuance of a National Interdiction Command and Control Plan. Requires the Coordinator to report to Congress on or before March 1 of each year.

Provides for an Interdiction Committee to: (1) discuss and resolve issues related to the coordination, oversight and integration of international, border, and domestic drug interdiction efforts in support of the National Drug Control Strategy; (2) review the annual National Interdiction Command and Control Plan; and (3) provide advice to the Director on drug interdiction strategy and policies. Requires the Chairman of the Committee to report to the Director and the appropriate congressional committees on Committee activities and findings.

(Sec. 104) Requires annual reports (by July 1) to the Director and the appropriate congressional committees from: (1) the Secretaries of Agriculture and the Interior on illegal drug cultivation and manufacturing in the United States; (2) the Secretaries of Homeland Security and Defense on drug seizures and air and maritime patrols; and (3) the Attorney General on arrests and prosecutions for drug violations and on drug seizures.

(Sec. 105) Revises National Drug Control Program budgetary procedures to: (1) require budget requests to include all funding requests for any drug control activity, including any drug law enforcement activities; (2) prohibit the Director from certifying a budget request which does not meet certain basic standards for drug control programs; and (3) require fund control notices to be transmitted to the appropriate congressional committees.

Title II: The National Drug Control Strategy - (Sec. 201) Revises requirements for the development, submission, implementation, and assessment of the National Drug Control Strategy (Strategy). Requires the President to submit an annual Strategy to Congress not later than February 1 of each year.

Expands the required content of the Strategy to include: (1) assessments of current illicit drug use and availability, impact of illicit drug use, and treatment availability; (2) a review of the research agenda of the Counterdrug Technology Assessment Center; (3) a summary of efforts to conduct private research and development of medications to treat addiction; (4) an assessment of of the effectiveness in achieving the National Drug Control Strategy for the previous year; and (5) a general review of demand reduction activities by private and community-based organizations, including faith-based organizations. Authorizes the President to submit a revised Strategy at any time.

(Sec. 202) Requires the Director to submit to Congress by February 1 of each year a description of a national drug control performance measurement system as part of the Strategy.

(Sec. 203) Requires the Director to report to Congress on or before February 1 of each year on the national drug control media campaign. Requires the Government Accountability Office to conduct annual audits of the Office of National Drug Control Policy and certain programs within the Office.

Title III: High Intensity Drug Trafficking Areas - (Sec. 301) Revises the High Intensity Drug Trafficking Areas (HIDTA) Program to: (1) identify specific purposes of such Program relating to inter-governmental cooperation and intelligence sharing; (2) allow coalitions of law enforcement agencies to petition for the designation of a high intensity drug trafficking area; (3) require the appointment of an Executive Board to manage such areas; (4) limit the use of HIDTA Program funding for the establishment of drug prevention programs; and (5) authorize the Director to use HIDTA Program funds to assist law enforcement agencies in terrorism prevention activities, to respond to emerging drug trafficking threats, and to combat methamphetamine trafficking.

Authorizes the Director to use up to 10% of appropriated funds to respond to any emerging drug trafficking threat in an existing high intensity drug trafficking area, to establish a new area, or expand an existing area.

Requires the Director to report to Congress on assessments of: (1) designated high intensity drug trafficking areas; (2) drug enforcement task forces within such areas; (3) intelligence sharing in such areas; and (4) the use of funds to combat methamphetamine trafficking.

Authorizes appropriations for FY2007-FY2011.

(Sec. 302) Dawson Family Community Protection Act - Requires the Director to allocate at least $7 million for high intensity drug trafficking areas with severe neighborhood safety and illegal drug distribution problems. Specifies the required uses of such funds as: (1) ensuring the safety of communities and preventing intimidation of potential witnesses of illegal drug distribution; and (2) combating illegal drug trafficking.

(Sec. 303) Requires the Director to conduct a demonstration project examining the ability of the New York/New Jersey HIDTA Program to respond to the movements of drug traffickers in certain New York counties.

Title IV: Technology - (Sec. 401) Replaces the Director of Technology of the Counterdrug Technology Assessment Center with a Chief Scientist. Sets forth the responsibilities of the Chief Scientist, including the coordination and implementation of a program for transferring counterdrug technology and associated training directly to state, local, and tribal law enforcement agencies. Requires the Director to report to the appropriate congressional committees by July 1 of each year on such program..

Title V: National Youth Media Campaign - (Sec. 501) Requires the Director to conduct a national youth anti-drug media campaign. Sets forth criteria for conducting such campaign, including testing and evaluation of advertising

Delegates to the Partnership for a Drug-Free America responsibility for: (1) developing and recommending strategies to achieve the goals of the campaign; and (2) the creation of advertising to be used in the campaign. Requires the Director to contract with a media buying contractor to plan and purchase advertising time and space for the campaign.

Establishes standards, limitations, and matching requirements for the use of federal funds for the campaign.

Requires the Director to submit an annual report to Congress on the campaign.

Authorizes the Director to emphasize prevention of youth marijuana use in conducting advertising and other activities.

Requires the Director to use not less than 10% of appropriated funds for advertisements specifically intended to reduce the use of methamphetamine.

Authorizes appropriations for FY2007-FY2011.

Repeals the Drug-Free Media Campaign Act of 1998 (superseded by this title).

Title VI: Authorizations and Extension of Termination Date - (Sec. 601) Authorizes appropriations for ONDCPRA for FY2006-FY2010 and extends its termination date until September 30, 2010 (previous termination date was September 30, 2003).

Title VII: Anti-Doping Agency - (Sec. 701) Designates the U.S. Anti-Doping Agency as the independent anti-doping organization for the amateur athletic competitions recognized by the U.S. Olympic Committee and sets forth its duties. Requires the Agency to: (1) keep correct and compete records of account; and (2) submit an annual report to Congress that includes an audit and description of Agency activities.

Authorizes appropriations for FY2007-FY2011.

Title VIII: Drug-Free Communities - (Sec. 801) Amends the Drug-Free Communities Act of 1997 to authorize appropriations for FY2008-FY2012. Limits the amount of funding which the Office of National Drug Control Policy and designated agencies may use for administrative costs.

(Sec. 802) Requires drug-free communities program grantees to be afforded a fair, timely, and independent appeal before suspension or termination for noncompliance with grant criteria. Requires the Director to report to Congress on the appeals processes established by such Act.

(Sec. 803) Increases from $100,000 to $125,000 the maximum grant amount allowed under such Act.

(Sec. 804) Prohibits the Director from imposing any new eligibility criteria on grant applicants.

(Sec. 805) Requires the Director to make a directed grant to Community Anti-Drug Coalitions of America to provide for the continuation of the National Community Antidrug Coalition Institute. Authorizes appropriations for FY2008-FY2012.

Title IX: National Guard Counterdrug Schools - (Sec. 901) Authorizes the Chief of the National Guard Bureau to establish and operate up to five schools to be known as National Guard counterdrug schools to provide training in drug interdiction and counterdrug activities and drug demand reduction activities to: (1) federal agencies; (2) state, local, and tribal law enforcement agencies; and (3) community-based organizations and other non-federal governmental and private entities engaged in counterdrug activities. Identifies such schools as: (1) the National Interagency Civil-Military Institute, San Luis Obispo, California; (2) the Mult-Jurisdictional Counterdrug Task Force Training Center, St. Petersburg, Florida; (3) the Midwest Counterdrug Training Center, Johnston, Iowa; (4) the Regional Counterdrug Training Academy, Meridian, Mississippi; and (5) the Northeast Regional Counterdrug Training Center, Fort Indiantown Gap, Pennsylvania.

Directs the Secretary of Defense to report to Congress by February 1 of each year on the activities of the National Guard counterdrug schools during the preceding year.

Authorizes appropriations for FY2006-FY2010.

Title X: National Methamphetamine Information Clearinghouse Act of 2006 - National Methamphetamine Information Clearinghouse Act of 2006 - (Sec. 1003) Establishes: (1) the National Methamphetamine Information Clearinghouse under the supervision of the Attorney General; and (2) the National Methamphetamine Advisory Council.

(Sec. 1004) Directs the Clearinghouse to: (1) promote information sharing on successful programs relating to methamphetamine production, use, or effects, and grants available for such programs; and (2) establish a toll free number and a website.

(Sec. 1005) Authorizes appropriations for FY2007-FY2009.

Title XI: Miscellaneous Provisions - (Sec. 1101) Repeals: (1) the Parents Advisory Council on Youth Drug Abuse established by the Office of National Drug Control Policy Reauthorization Act of 1998; and (2) the Special Forfeiture Fund established by the Assets Forfeiture Amendments Act of 1988.

(Sec. 1102) Amends the Controlled Substances Act to permit non-group medical practitioners to dispense narcotic drugs for drug maintenance and detoxification treatment to up to 100 patients at any one time (currently, limited to 30 patients), after giving certain notifications and certifications to the Secretary of Health and Human Services.

Requires the Director to submit to Congress reports on: (1) law enforcement intelligence systems for drug trafficking and drug production enforcement; (2) comprehensive strategies for addressing the threats from South American and Afghan heroin; (3) a strategy to stop advertisements on the Internet for obtaining prescription drugs without a lawful prescription; (4) illegal diversion and inappropriate uses of prescription drugs; (5) drug court hearings in nontraditional public places; (6) the use of mycoherbicide for eliminating illicit drug crops; (7) state precursor chemical control laws; (8) methamphetamine-related activities conducted by state-administered drug endangered children programs; (9) the representation of tribal governments in the High Intensity Drug Trafficking Areas Program; and (10) drug testing in schools.

(Sec. 1105) Requires the Director to enter into an agreement with a tax-exempt corporation to: (1) advise states on establishing laws and policies to address alcohol and other drug issues, based on model state drug laws; and (2) revise such model state drug laws and draft supplementary model laws to consider changes in alcohol and drug abuse problems. Authorizes appropriations for FY2007-FY2011.

(Sec. 1106) Requires the Director to enter into an agreement with the Institute of Medicine of the National Academy of Sciences to study certain aspects of iatrogenic addiction to prescription opioid analgesic drugs.

(Sec. 1110) Requires the Director to submit to Congress a Southwest Border Counternarcotics Strategy for preventing the illegal trafficking of drugs between Mexico and the United States. Requires such Strategy to include a strategy to end the construction and use of tunnels and passages between Mexico and the United States for illegal trafficking of drugs. Requires the Director to provide a copy of the Strategy to specified congressional committees and to present any classified law enforcement information separately.

(Sec. 1117) Requires the Director to report to Congress on performance bonuses paid to employees of the Office of National Drug Control Policy since October 1, 2004.

(Sec. 1118) Requires the Office, in making any advertisement or other communication, to disclose to the target audience whether it has paid for such advertisement or communication.

(Sec. 1119) Requires the Director to: (1) make awards to fund demonstration programs by eligible partnerships to reduce the use of illicit drugs by chronic hard-drug users; and (2) submit to Congress an interim report by June 1, 2009, and a final report by June 1, 2010, on the best practices for reducing the use of illicit drugs by chronic hard-drug users. Authorizes appropriations for FY2007-FY2009. Defines "eligible partnership" for purposes of this program.

(Sec. 1120) Requires the Director to base any policy relating to syringe exchange programs for intravenous drug users on the best available medical and scientific evidence and to consult with the National Institutes of Health and the National Academy of Sciences in making such policy.